S&P 500   2,996.95 (+0.03%)
DOW   26,837.86 (+0.19%)
QQQ   191.70 (-0.08%)
AAPL   242.43 (+1.03%)
MSFT   136.51 (+0.10%)
GOOGL   1,250.98 (+0.79%)
AMZN   1,753.04 (-0.72%)
CGC   21.12 (-0.14%)
NVDA   193.87 (-0.89%)
BABA   170.25 (+0.21%)
GE   9.04 (-0.22%)
TSLA   253.06 (-0.99%)
AMD   31.20 (-0.98%)
T   38.02 (-0.39%)
F   9.02 (-0.55%)
ACB   3.56 (-0.56%)
PRI   125.75 (-0.04%)
NFLX   271.78 (+1.91%)
BAC   31.25 (+0.16%)
GILD   65.98 (+0.18%)
S&P 500   2,996.95 (+0.03%)
DOW   26,837.86 (+0.19%)
QQQ   191.70 (-0.08%)
AAPL   242.43 (+1.03%)
MSFT   136.51 (+0.10%)
GOOGL   1,250.98 (+0.79%)
AMZN   1,753.04 (-0.72%)
CGC   21.12 (-0.14%)
NVDA   193.87 (-0.89%)
BABA   170.25 (+0.21%)
GE   9.04 (-0.22%)
TSLA   253.06 (-0.99%)
AMD   31.20 (-0.98%)
T   38.02 (-0.39%)
F   9.02 (-0.55%)
ACB   3.56 (-0.56%)
PRI   125.75 (-0.04%)
NFLX   271.78 (+1.91%)
BAC   31.25 (+0.16%)
GILD   65.98 (+0.18%)
Log in

Unum Therapeutics SEC Filings & 10K Form (NASDAQ:UMRX)

$1.31
-0.01 (-0.76 %)
(As of 10/23/2019 09:46 AM ET)
Today's Range
$1.30
Now: $1.31
$1.31
50-Day Range
$1.30
MA: $1.68
$2.10
52-Week Range
$1.23
Now: $1.31
$9.27
Volume467 shs
Average Volume41,400 shs
Market Capitalization$40.16 million
P/E RatioN/A
Dividend YieldN/A
Beta1.26

SEC Filings

Unum Therapeutics (NASDAQ:UMRX) SEC Filings

DateFilerForm TypeView
10/03/2019
3:42 PM
Ros Matthew (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2019
3:41 PM
Ferrante Karen Jean (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2019
3:39 PM
Booth Bruce (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2019
3:37 PM
Aldag Jorn (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2019
3:19 PM
Unum Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2019
3:12 PM
Unum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2019
4:27 PM
Unum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2019
3:10 PM
Ros Matthew (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2019
3:09 PM
Ros Matthew (Reporting)
Unum Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/29/2019
3:06 PM
Morris Arlene (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2019
3:05 PM
Morris Arlene (Reporting)
Unum Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/29/2019
6:24 AM
Unum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2019
3:47 PM
Unum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2019
3:26 PM
Sachs Jessica (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2019
4:30 PM
Sachs Jessica (Reporting)
Unum Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/03/2019
3:04 PM
Aldag Jorn (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
3:51 PM
Osborne Matthew Scott (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
3:49 PM
Osborne Matthew Scott (Reporting)
Unum Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/25/2019
3:30 PM
Unum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2019
3:17 PM
Ferrante Karen Jean (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2019
3:14 PM
Booth Bruce (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2019
3:13 PM
Aldag Jorn (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2019
3:51 PM
Unum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2019
3:27 PM
Ratcliffe Liam (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2019
3:25 PM
PEREZ ROBERT J (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2019
6:13 AM
Unum Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2019
6:10 AM
Unum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2019
11:15 PM
Unum Therapeutics (Filer)
Form EFFECT
04/30/2019
4:27 PM
Unum Therapeutics (Filer)
Form DEFA14A
04/30/2019
4:25 PM
Unum Therapeutics (Filer)
Form DEF 14A
04/26/2019
3:32 PM
Green John L. (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2019
4:08 PM
Green John L. (Reporting)
Unum Therapeutics (Issuer)
Form 4/A
04/11/2019
3:41 PM
Unum Therapeutics (Issuer)
WILSON CHARLES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2019
3:39 PM
Unum Therapeutics (Issuer)
VASCONCELLES MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2019
3:36 PM
HODGE GEOFFREY (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2019
3:34 PM
Green John L. (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2019
3:30 PM
Ettenberg Seth (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
3:29 PM
PEREZ ROBERT J (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
3:26 PM
Ferrante Karen Jean (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
3:24 PM
Booth Bruce (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
3:17 PM
Aldag Jorn (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2019
7:21 PM
Unum Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/28/2019
6:50 AM
Unum Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/28/2019
6:31 AM
Unum Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/28/2019
6:12 AM
Unum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2019
3:23 PM
Ettenberg Seth (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2019
3:29 PM
BlackRock Inc. (Filed by)
Unum Therapeutics (Subject)
Form SC 13G/A
03/07/2019
1:02 PM
Unum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2019
3:36 PM
Ettenberg Seth (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2019
3:40 PM
New Leaf Ventures III, L.P. (Filed by)
Unum Therapeutics (Subject)
Form SC 13G
02/13/2019
11:06 AM
FMR LLC (Filed by)
Unum Therapeutics (Subject)
Form SC 13G/A
02/11/2019
4:02 PM
Green John L. (Reporting)
Unum Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/11/2019
7:33 AM
Sanofi (Filed by)
Unum Therapeutics (Subject)
Form SC 13G
02/08/2019
5:04 AM
Atlas Venture Fund IX, L.P. (Filed by)
Unum Therapeutics (Subject)
Form SC 13G
01/07/2019
7:02 AM
Unum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2019
3:57 PM
Ratcliffe Liam (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
3:55 PM
PEREZ ROBERT J (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
3:54 PM
Ferrante Karen Jean (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
3:52 PM
Booth Bruce (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
3:50 PM
Aldag Jorn (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2019
6:23 AM
Unum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2018
6:09 PM
Ettenberg Seth (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2018
6:50 AM
Unum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2018
6:54 PM
Ettenberg Seth (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2018
8:03 AM
Unum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2018
7:49 AM
Unum Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/29/2018
3:41 PM
Ettenberg Seth (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2018
4:19 PM
Ratcliffe Liam (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2018
4:16 PM
PEREZ ROBERT J (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2018
4:14 PM
Ferrante Karen Jean (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2018
4:12 PM
Booth Bruce (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2018
4:10 PM
Aldag Jorn (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/26/2018
5:47 PM
Ratcliffe Liam (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/26/2018
5:46 PM
PEREZ ROBERT J (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/26/2018
5:43 PM
Ferrante Karen Jean (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/26/2018
5:41 PM
Ettenberg Seth (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/26/2018
5:39 PM
Booth Bruce (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/26/2018
5:37 PM
Aldag Jorn (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2018
3:32 PM
Unum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2018
3:10 PM
Unum Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2018
6:04 AM
Unum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2018
6:01 AM
Unum Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/05/2018
11:35 AM
FMR LLC (Filed by)
Unum Therapeutics (Subject)
Form SC 13G
04/05/2018
11:28 AM
FIL Ltd (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2018
11:27 AM
FMR LLC (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2018
3:44 PM
Unum Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/03/2018
4:11 PM
Atlas Venture Associates IX, L.P. (Reporting)
Atlas Venture Associates IX, LLC (Reporting)
Atlas Venture Fund IX, L.P. (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2018
4:07 PM
Booth Bruce (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2018
3:30 PM
Ratcliffe Liam (Reporting)
Unum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2018
4:28 PM
Unum Therapeutics (Filer)
Form 424B4
03/29/2018
11:14 AM
FMR LLC (Reporting)
Unum Therapeutics (Issuer)
Form 3/A
03/29/2018
11:06 AM
FIL Ltd (Reporting)
Unum Therapeutics (Issuer)
Form 3/A
03/28/2018
11:15 PM
Unum Therapeutics (Filer)
Form EFFECT
03/28/2018
8:10 PM
Atlas Venture Associates IX, L.P. (Reporting)
Atlas Venture Associates IX, LLC (Reporting)
Atlas Venture Fund IX, L.P. (Reporting)
Unum Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/28/2018
8:06 PM
Booth Bruce (Reporting)
Unum Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/28/2018
8:03 PM
Aldag Jorn (Reporting)
Unum Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/28/2018
8:03 PM
CAMPANA DARIO (Reporting)
Unum Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/28/2018
8:02 PM
Ferrante Karen Jean (Reporting)
Unum Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/28/2018
8:01 PM
Ettenberg Seth (Reporting)
Unum Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/28/2018
8:00 PM
PEREZ ROBERT J (Reporting)
Unum Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
This page was last updated on 10/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel